Other
The problems healthtech and biotech startups in Australia are solving
Between bone repair glue and gene splicing, there is a diverse range of startups working to improve our health or innovate the way the sector operates.
Between bone repair glue and gene splicing, there is a diverse range of startups working to improve our health or innovate the way the sector operates.
After receiving a $1 million grant through the Federal Government’s Accelerating Commercialisation program earlier this year, biotech company Clarity Pharmaceuticals has announced it has raised a further $2 million in funding to help further develop its technology.
Clinical Genomics, a biotechnology company working across the United States and Australia, has closed a US$15 million ($19.7 million) round led by Sydney-based VC firm OneVentures.